Ahold Delhaize Agrees to Pay $40 Million Settlement
The multistate settlement resolves False Claims Act allegations over inflated prescription drug prices reported to federal health programs.
Updated on Nov. 8, 2026 in Healthcare
Live Poll
Do you trust large retailers to report drug prices accurately to government programs?
Attorney General Jeff Jackson announced a $40 million multistate settlement with Ahold Delhaize, which owns Food Lion, Giant, Hannaford and Stop & Shop. North Carolina will receive $503,460 in restitution and other recoveries.
Why it matters
The settlement resolves allegations that supermarket prescription savings programs led to inflated usual and customary prices reported to Medicare Part D, Medicaid and TRICARE, causing those programs to pay more than they should have. The case arose from a whistleblower lawsuit and reflects coordinated state and federal enforcement of health care fraud.
The $40 million settlement is the headline figure, with North Carolina receiving $503,460 in restitution and other recoveries. The release does not break down how the remaining funds are allocated among the participating states or federal agencies.
The players
Jeff Jackson
Jeff Jackson is the North Carolina Attorney General who announced the multistate settlement and the state's share of recoveries.
Ahold Delhaize
Ahold Delhaize is a multinational grocery retailer that owns supermarkets including Food Lion, Giant, Hannaford and Stop & Shop.
The details
Ahold Delhaize supermarkets offered prescription savings programs giving members discounted prices, but those discounted prices were allegedly not reported as usual and customary prices on claims to federal programs. The National Association of Medicaid Fraud Control Units team worked with the U.S. Department of Justice and the U.S. Attorney's Office for the Western District of Pennsylvania on the case.
Timeline
Settlement announcement was published on November 8, 2026.
Attorney General Jeff Jackson announced the $40 million settlement earlier this week.
The Medicaid Investigations Division's FY 2027 grant award and state funding period apply to the agency's current work.
Healthcare Enforcement
The settlement applies the federal False Claims Act to prescription pricing reported to Medicare Part D, Medicaid and TRICARE, extending the statute to retail pharmacy savings programs. It follows the pattern of whistleblower-driven, multistate enforcement by state Medicaid fraud units working alongside federal prosecutors.
Prescription savings programs at grocery chains can carry pricing reporting that affects federal health programs, so the reported price of a drug may differ from the discounted price a member pays. The settlement does not change what individual shoppers pay at checkout, and it does not specify any refunds to consumers.
The takeaway
Discounted pharmacy prices and the prices reported to federal health programs can be different measures, and that gap was the basis of this case. Readers using prescription savings programs can compare the membership price with their insurance-covered cost when filling a prescription.
Further reading
Explore more in Healthcare coverage across the United States.
Source note: This article includes information reported by Salisbury Post.
Live Poll
Do you trust large retailers to report drug prices accurately to government programs?
